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The double-positive (DP) to single-positive (SP) tran-
sition during T cell development is initiated by down-
regulation of the E protein transcription factors HEB
and E2A. Here, we have demonstrated that in addi-
tion to regulating the onset of this transition, HEB
and E2A also play a separate role in CD4+ lineage
choice. Deletion of HEB and E2A in DP thymocytes
specifically blocked the development of CD4+
lineage T cells. Furthermore, deletion of the E protein
inhibitors Id2 and Id3 allowed CD4+ T cell develop-
ment but blocked CD8+ lineage development. Anal-
ysis of the CD4+ lineage transcriptional regulators
ThPOK and Gata3 placed HEB and E2A upstream
of CD4+ lineage specification. These studies identify
an important role for E proteins in the activation of
CD4+ lineage differentiation as thymocytes undergo
the DP to SP transition.
INTRODUCTION
The development of CD4+ and CD8+ lineage ab T cells in the
thymus is carefully regulated by developmental checkpoints
that ensure proper T cell receptor (TCR) expression and selec-
tion and the appropriate determination of lineage choice
(Carpenter and Bosselut, 2010). Of these, the TCR selection
checkpoint at the CD4+CD8+ double-positive (DP) stage is crit-
ical for ensuring that each ab T cell proceeding to the subse-
quent CD4+ or CD8+ single-positive (SP) stage expresses a
functional TCR, capable of recognition of peptide presented by
major histocompatibility complex class I (MHC I) or class II
(MHC II) molecules. In addition to this positive selection step,
cells expressing an autoreactive TCR can undergo negative
selection, eliminating them from the mature T cell pool (von
Boehmer and Kisielow, 2006).
The DP to SP transition also involves the critical decision to
enter either the CD4+ or CD8+ lineage (Singer et al., 2008). First,
positively selected DP thymocytes progress through a transi-348 Immunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc.tional CD4+CD8lo stage (He et al., 2010), where the lineage
choice decision is suggested to occur (Brugnera et al., 2000).
Then, depending on the MHC specificity of their TCR, cells will
proceed to either the CD4+ or CD8+ lineage, expressing only
the CD4 or CD8 coreceptor, respectively. Precise transcriptional
regulation of CD4+ versus CD8+ lineage choice ensures proper
functional divergence and matching of coreceptor and TCR
specificity (CD4+ and MHC II restriction or CD8+ and MHC I
restriction). How the TCR signal translates into activation of
CD4+ versus CD8+ lineage transcriptional programs is still a topic
of great interest and debate.
The E protein transcription factors HEB and E2A are critical
regulators of the DP to SP transition. E proteins are required at
the DP stage to enforce positive selection, maintaining expres-
sion of DP-associated genes while repressing expression of
SP-associated genes (Jones and Zhuang, 2007). Upon receipt
of a TCR-mediated positive selection signal, E protein activity
is downregulated and cells proceed to the SP stage (Bain
et al., 2001; Engel et al., 2001; Pan et al., 2002). We have shown
previously that the removal of both HEB and E2A at the DP stage
is sufficient for cells to initiate SP development in the absence of
a TCR signal, suggesting that the downregulation of E proteins in
response to a TCR-mediated positive selection signal is the
molecular switch controlling DP to SP differentiation (Jones
and Zhuang, 2007). Because the majority of cells, both TCR+
and TCR, proceeding to the SP stage in the absence of
HEB and E2A were CD8+, we hypothesized that E proteins
may play additional roles in regulating CD4+ versus CD8+ lineage
choice. Even though E proteins are downregulated during the
window when cells undergo lineage choice, it was still possible
that there were additional functions yet to be described for E
proteins during the DP to SP transition. We therefore asked the
following questions: are E proteins specifically required for the
development of CD4+ cells? If so, when during the CD4+ lineage
developmental process are they required? What E protein
targets may be disrupted to cause the absence of CD4+ cells
upon removal of both HEB and E2A?
Here, we utilized our Tcf12f/fTcfe2af/fCd4cre double condi-
tional deletionmodel for the removal of Tcf12, the gene encoding
HEB, and Tcfe2a (also known as Tcf3), the gene encoding E2A,
at the DP stage of thymocyte development. Through the use of
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that E proteins are required for the development of CD4+ T cells,
and MHC II-restricted thymocytes can instead enter the CD8+
lineage in the absence of HEB and E2A. Perturbation of E protein
downregulation by removal of the E protein inhibitors Id2 and Id3
further supported a role for E proteins in directing CD4+ develop-
ment, at the expense of CD8+ development. Analysis of CD4+
lineage factors and potential E protein targets placed E proteins
upstream of CD4+ lineage specification. We propose that proper
regulation of the timing or amount of E protein downregulation
during the DP to SP transition is critical to allow for CD4+ lineage
development. In addition to revealing a role for E proteins in
CD4+ T cell development, this work identifies E proteins as tran-
scriptional regulators controlling both positive selection and
lineage choice, serving to further elucidate the enigmatic rela-
tionship between these two events.
RESULTS
CD4+ Lineage T Cells Fail to Develop in the Absence
of HEB and E2A
Initial analysis of the Tcf12f/fTcfe2af/fCd4cre+ mice demon-
strated a severe defect in the CD4+ T cell compartment in both
the thymus and periphery (Jones and Zhuang, 2007). Because
this defect could be due to either a failure of CD4+ T cells to
develop or enhanced negative selection of CD4 SP thymocytes,
we first determinedwhether inhibition of negative selection could
rescue the CD4+ population. Two approaches were taken to
analyze the effect of eliminating mediators of negative selection.
First, Tcf12f/fTcfe2af/fCd4cre+ mice were crossed with Bim-
deficient mice (Bcl2l11/), a model defective in cell death of
negatively selected thymocytes (Bouillet et al., 2002). Elimination
of Bim, however, failed to significantly rescue the CD4 SP defect
observed in Tcf12f/fTcfe2af/fCd4cre+ mice (Figure 1A). Second,
Tcf12f/fTcfe2af/fCd4cre+ mice were crossed with MHC I and
MHC II double-deficient mice. Even though CD8+ T cells can
develop in the absence of a TCR upon removal of HEB and
E2A (Jones and Zhuang, 2007), we reasoned that an MHC-
mediated TCR signal would still be required to induce negative
selection among the population of thymocytes successfully ex-
pressing a TCR on their cell surface. Therefore, because the
CD4 SP thymocytes in Tcf12f/fTcfe2af/fCd4cre+ mice are TCR+,
removal of both MHC I and MHC II was an additional test to
determine whether blocking the negative selection signal could
rescue this population. However, similar to the Bim deficiency,
there was no rescue of CD4 SP cells upon removal of MHC I
and MHC II, through use of b2 microglobulin (B2m)- and Abb-
targeted mice, respectively (Figure 1B). In fact, the CD4 SP
defect was more severe in Tcf12f/fTcfe2af/fAbb/B2m+/
Cd4cre+ and Tcf12f/fTcfe2af/fAbb/B2m/Cd4cre+ mice than
in Tcf12f/fTcfe2af/fCd4cre+ mice. This result confirmed that the
development of the CD4+TCR+ T cells observed in Tcf12f/f
Tcfe2af/fCd4cre+ mice requires MHC II- and TCR-mediated
positive selection, indicating that these cells represent a small
population of MHC II-restricted thymocytes probably receiving
a positive selection signal prior to complete loss of residual
HEB and E2A protein.
The failure of Bim or MHC I and MHC II deficiency to rescue
CD4 SP cells in the thymus, which is also reflected in analysisof the peripheral CD4+ T cell compartment in the spleen of
these animals (Figures S1A and S1B available online), suggested
that enhanced negative selection is not the major factor driving
the CD4+ T cell phenotype in Tcf12f/fTcfe2af/fCd4cre+ mice.
The absence of CD4+ T cells upon removal of MHC II demon-
strated that CD4+ T cells fail to develop independently of TCR
signaling in the absence of HEB and E2A. This result is specific
to the CD4+ lineage as shown by the fact that CD8+ T cells,
both TCR and TCR+, continue to be produced in the absence
of both MHC I- and MHC II-mediated selection (Figure S1C).
Together, these findings indicate that the reduced CD4+
compartment in Tcf12f/fTcfe2af/fCd4cre+ mice results from a
failure to generate CD4+ lineage T cells.
Removal of E Proteins Drives CD4+ Lineage-Destined
Cells to the CD8+ Lineage
If CD4+ lineage T cells fail to develop in the absence of HEB and
E2A, are MHC II-restricted thymocytes blocked in their develop-
ment or can they instead proceed by entering the CD8+ lineage?
To address this question, we next crossed the Tcf12f/fTcfe2af/f
Cd4cre+ mice onto an OT-II TCR transgenic background. OT-II
transgenic mice express a MHC II-restricted TCR, composed
of a Vb5 and a Va2 chain, which drives primarily CD4+ T cell
production (Barnden et al., 1998). However, analysis of Tcf12f/f
Tcfe2af/fCd4cre+OT-II+ mice revealed an increased ratio of
CD8+:CD4+ in both the thymus and spleen, similar to that of
Tcf12f/fTcfe2af/fCd4cre+ mice alone (Figure 2A). To confirm that
CD8+ T cells expressing the components of the OT-II transgenic
TCR were being generated in Tcf12f/fTcfe2af/fCd4cre+OT-II+
mice, Vb5- and Va2-expressing populations among splenic
T cells and thymocytes were analyzed. Indeed, a large popula-
tion of CD8+ T cells costained positive for Vb5 and Va2 in
Tcf12f/fTcfe2af/fCd4cre+OT-II+ mice, and the percent of CD8+
T cells within the Vb5+Va2+ compartment was significantly
higher in Tcf12f/fTcfe2af/fCd4cre+OT-II+ mice when compared
to Tcf12f/fTcfe2af/fCd4creOT-II+ mice (Figures 2B and S2A),
revealing that developing thymocytes that would normally be
directed to the CD4+ lineage, as seen in the Tcf12f/fTcfe2af/f
Cd4creOT-II+ control, could instead become CD8+ T cells in
the absence of HEB and E2A.
To confirm that the CD8+Vb5+Va2+ cells developing in the
Tcf12f/fTcfe2af/fCd4cre+OT-II+ mice could be activated and
behave like CD8+ lineage T cells, we isolated and stimulated
splenocytes in vitro. Even though these CD8+ cells expressed
the components of a MHC II-restricted TCR, they were able to
produce IFN-g, upregulate the activation marker CD69, and
proliferate upon stimulation (Figures S2B–S2D). Together, these
results suggest that the removal ofHEBandE2Ablocks the ability
of thymocytes to become CD4+ lineage T cells, and the resulting
E-protein-deficient cells undergo the DP to SP transition to
become CD8+ lineage T cells, independent of TCR expression
and specificity. E proteins are therefore required (1) for ensuring
that T cells express a functional TCRand (2) for ensuring that cells
enter the appropriate lineage to match their TCR specificity.
Removal of the E Protein Negative Regulators Id2
and Id3 Permits CD4+ Lineage T Cell Development
Downregulation of E protein activity upon receipt of a TCR-medi-
ated positive selection signal is largely mediated by induction ofImmunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc. 349
Figure 1. Elimination of Negative Selection Mediators Fails to Rescue the CD4+ T Cell Defect
(A) Tcf12f/fTcfe2af/fCd4cre+ mice were crossed onto a Bim-deficient background (Bcl2l11/). Representative staining of thymus from indicated genotypes. Total
thymocyte cell number means ± SD (3108) for 1- to 2-month-old mice were 1.9 ± 0.97 for control (n = 5), 2.4 ± 0.55 forBcl2l11/ (n = 4), 1.5 ± 0.30 for cre+ (n = 5),
and 2.3 ± 1.3 for cre+Bcl2l11/ (n = 7). Percentages in each quadrant are displayed. Percent means ± SD for the CD4 SP (CD4+CD8) gate were 18 ± 4.9 for
control (n = 5), 21 ± 8.5 for Bcl2l11/ (n = 5), 1.7 ± 0.37 for cre+ (n = 6), and 4.5 ± 3.1 for cre+Bcl2l11/ (n = 7).
(B) Tcf12f/fTcfe2af/fCd4cre+ mice were crossed onto MHC class I- (B2m/) and/or class II- (Abb/) deficient backgrounds. Representative staining of thymus
from indicated genotypes. Total thymocyte cell numbermeans ± SD (3108) for 1.5- to 4-month-oldmice were 1.9 ± 1.2 for control (n = 3), 1.3 ± 0.48 for cre+ (n = 4),
0.67 ± 0.32 for Abb/cre+ (n = 4), and 1.2 ± 0.76 for Abb/B2m/cre+ (n = 5). Percentages in each quadrant are displayed. Percent means ± SD for the CD4 SP
(CD4+CD8) gate were 10 ± 1.9 for control (n = 3), 1.5 ± 0.61 for cre+ (n = 4), 0.60 ± 0.088 forAbb/cre+ (n = 4), and 0.30 ± 0.14 forAbb/B2m/cre+ (n = 5). CD4
SP percent values forAbb/cre+ andAbb/B2m/cre+ are significantly different from cre+ (p = 0.023 and p = 0.003, respectively). Abb/cre+ animals used for
these statistics are either B2m+/ or B2m+/+.
See also Figure S1.
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E Proteins Allow for CD4+ Lineage Choicethe E protein inhibitor Id3 (Bain et al., 2001; Engel et al., 2001).
The mammalian Id family consists of four members (Id1–Id4),
which form heterodimers with E proteins to inhibit E-protein-
DNA-binding activity (Benezra et al., 1990). Of these Id family
members, primarily Id3 and Id2 are expressed during T cell
development (Engel et al., 2001; Wikstro¨m et al., 2008). Because
Id3-deficient mice demonstrate only a partial block in DP to SP
development (Rivera et al., 2000), we hypothesized that Id2
may be performing a similar function and compensating in the
absence of Id3 to downregulate E protein activity and allow cells
to develop beyond the DP stage. In addition, even though the
absence of Id3 does not demonstrate a bias for CD4+ over
CD8+ T cell development (Guo et al., 2011; Pan et al., 1999; Riv-
era et al., 2000), as could be anticipated given our E-protein-defi-350 Immunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc.cient phenotype, we wondered whether the removal of both Id3
and Id2 would exhibit this effect on lineage choice by more
strongly perturbing E protein downregulation.
First, we investigated the expression pattern of Id3 and Id2 at
the single cell level during DP to SP thymocyte development. Id3
has previously been shown by RT-PCR to be induced in TCR-
signaled thymocytes (Bain et al., 2001; Engel et al., 2001), and
time course analysis suggests that Id3 is rapidly and transiently
expressed in response to this stimulation (Schmitz et al., 2003).
In addition, single cell analysis of Id3 expression, with an Id3RFP
reporter mouse (McMahon et al., 2008), is consistent with rapid
Id3 upregulation in thymocytes undergoing positive selection
(Figure 3A). This result is also consistent with a recent study
utilizing an Id3GFP allele (Miyazaki et al., 2011). Id2 has been
Figure 2. Deletion of E Proteins on a TCR Transgenic Background Generates CD8+ T Cells Expressing Components of a MHC II-Restric-
ted TCR
Tcf12f/fTcfe2af/fCd4cre+ mice were crossed onto an OT-II TCR transgenic background.
(A) Representative staining of thymus and spleen from indicated genotypes. Percentages in each quadrant are displayed. Percent means ± SD for the CD4 SP
(CD4+CD8) thymocyte gate were 11 ± 0.74 for control (n = 5), 28 ± 2.1 for OT-II+ (n = 5), 3.3 ± 1.8 for cre+ (n = 4), and 5.2 ± 2.1 for cre+OT-II+ (n = 7). Percent
means ± SD for the splenocyte CD4+ T (CD4+CD8) and CD8+ T (CD4CD8+) gates, respectively, were 18 ± 5.7 (n = 5) and 8.7 ± 2.3 (n = 7) for control, 17 ± 4.6
(n = 4) and 2.2 ± 0.63 (n = 5) for OT-II+, 4.8 ± 0.92 (n = 4) and 29 ± 9.2 (n = 5) for cre+, and 7.6 ± 2.2 (n = 6) and 21 ± 11 (n = 8) for cre+OT-II+.
(B) Representative staining of spleen from indicated genotypes. Plots are pregated on CD4+ or CD8+ cells, as labeled. Percentages in each quadrant are dis-
played. Percent means ± SD for the splenocyte Va2+Vb5+ gate within the CD8+ T cell compartment were 1.4 ± 0.32 (n = 5) for control, 14 ± 5.2 (n = 3) for OT-II+,
0.20 ± 0.044 (n = 3) for cre+, and 35 ± 17 (n = 6) for cre+OT-II+.
See also Figure S2.
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E Proteins Allow for CD4+ Lineage Choicesuggested to be induced during the DP to SP transition as well
(Huang et al., 2004; Wang et al., 2006) but with delayed kinetics
when compared to Id3 expression (Schmitz et al., 2003). To
further investigate the expression pattern of Id2 during thymo-
cyte development, we developed an Id2hCD5 reporter allele by
inserting an internal ribosome entry site (IRES)-driven, tailless
human-CD5 cDNA cassette into the 30 untranslated region of
the Id2 gene (Figures S3A and S3B). In this model, the coding
region of Id2 remains intact, and hCD5 surface expression is
used as a reporter of Id2 transcription. Expression of the hCD5
reporter is clearly observed within the Id2-dependent (Yokotaet al., 1999) NK cell (NK1.1+) compartment and is also detected
within the ab and gd T cell lineages (Figures S3C and S3D). In
addition, Id2hCD5/hCD5 mice express Id2 at amounts comparable
to that of wild-type controls during thymocyte development (Fig-
ure S3E). Single cell analysis of hCD5 expression demonstrated
slight upregulation of Id2 expression in positively selected DP
thymocytes with expression further increasing as cells transition
through the transient CD4+CD8lo compartment and into both the
CD4 and CD8 SP stages (Figures 3B and S3F–S3H). These
results are consistent with previous RT-PCR analysis (Wang
et al., 2006) and suggest that although the kinetics may beImmunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc. 351
Figure 3. Id3 and Id2 Are Upregulated from the DP to SP Stage
(A) Because the Id3RFP reporter allele design results in the disruption of the Id3 gene, we analyzed Id3RFP/+ animals here. Mean values for RFP expression in B6
(Id3+/+) and Id3RFP/+ populations are indicated, and data are representative of analysis of three Id3RFP/+ mice.
(B) Mean values for expression of hCD5 in B6 (Id2+/+) and Id2hCD5/hCD5 populations are indicated, and data are representative of analysis of three Id2hCD5/hCD5
mice.
Histograms are pregated on the following thymic populations: DP (CD4+CD8+), positively selected DP (CD4+CD8+TCRb+CD69+), CD4+CD8lo (CD4+CD8lo), CD4
SP (CD4+CD8), and CD8 SP (CD4CD8+TCRb+). See also Figure S3.
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E Proteins Allow for CD4+ Lineage Choicedelayed (Schmitz et al., 2003), Id2 expression corresponds with
that of Id3 during the DP to SP transition.
Because the expression pattern of Id2 suggested that it may
serve redundant function with Id3 to downregulate E protein
activity, the effect of removing both Id2 and Id3 at the DP stage,
by use of a conditional Id2f/fId3f/fCd4cremouse model, was then
investigated. In fact, Id2f/fId3f/fCd4cre+ mice did display the ex-
pected defect in DP to SP development, further highlighted by
the accumulation of TCRb+ cells within the DP and CD4+CD8lo
gates (Figure 4A). The increased percentage of CD69+ cells de-
tected within the DP gate was also supportive of an accumula-
tion of positively selected thymocytes resulting from delayed
differentiation into the SP stage.
In addition to the defect in progression of positively selected
cells, there was also a differential effect on the generation of
CD4 versus CD8 SP thymocytes in these Id-deficient animals.
CD8 SP development demonstrated a near complete block,
whereas CD4 SP development was permissible. The unchanged
total thymocyte numbers and the reduction of CD4 SP cell
numbers suggested that CD4+ T cell development was limited
(Figures 4B and 4C), but analysis of TCRb+ thymocytes
clearly showed that the CD4+ lineage pathway remains viable
upon deletion of Id2 and Id3 (Figure 4A). DNA analysis of Id2
and Id3 deletion in Id2f/fId3f/fCd4cre+ thymocytes confirmed effi-
cient deletion at the DP stage (Figure S4A). Complete deletion of
Id2 and Id3 appeared to be necessary and sufficient for the
observed phenotype because SP thymocyte development in352 Immunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc.mice that retain one allele of either Id2 or Id3 was comparable
to that of cre controls (Figure S4B). Peripheral analysis of
T cells in these mice also demonstrated a reduction in the
CD4+ T cell compartment and a nearly absent CD8+ T cell
compartment (Figure S4C). Faint Id2 and Id3 floxed bands
were observed in deletion analysis of splenic Id2f/fId3f/fCd4cre+
CD4+ T cells, suggesting that there may be some peripheral
selective pressure for any cells escaping complete deletion
(Figure S4D). However, comparison to a heterozygous control
verified that the majority of peripheral T cells had undergone effi-
cient deletion of both Id2 and Id3, as expected from the efficient
deletion observed in the thymus (Figure S4A).
To further characterize the CD4 SP population in the
Id2f/fId3f/fCd4cre+ mice and to determine which events during
the DP to SP transition are Id dependent, we examined the
expression dynamics of surface receptors that are functionally
important during this transition (Carpenter and Bosselut, 2010).
Although expression of the chemokine receptor CXCR4 was
properly downregulated in Id2f/fId3f/fCd4cre+ CD4 SP thymo-
cytes, both the chemokine receptor CCR7 and cytokine receptor
IL-7Ra failed to be efficiently upregulated in the absence of
Id2 and Id3 (Figures 5A and 5B). Next, we analyzed the expres-
sion of two transcription factors, KLF2 and Tox, which are
normally upregulated upon positive selection (Kuo et al., 1997;
Wilkinson et al., 2002). Both KLF2 and Tox were expressed in
Id2f/fId3f/fCd4cre+ CD4 SP thymocytes, comparably to cre
controls (Figure 5C). Together, these results further indicate
Figure 4. CD4+ T Cells Can Develop in the Absence of Id2 and Id3
(A) Representative staining of thymus from indicated genotypes. First row graphs display total live thymocytes. Second row graphs are pregated on DP or total
TCRb+ thymocytes, as shown. Percentages in each gated population are displayed. Percent means ± SD for the CD4 SP (CD4+CD8) gate within the TCRb+
compartment were 59 ± 5.5 for cre (n = 14) and 24 ± 11 for cre+ (n = 14), with a significant difference (p < 0.001). Percent means ± SD for the CD8 SP (CD4CD8+)
gate within the TCRb+ compartment were 15 ± 2.0 for cre (n = 14) and 0.87 ± 0.84 for cre+ (n = 14), with a significant difference (p < 0.001).
(B) Cell number in the thymus of 1- to 2-month-old mice (n = 16).
(C) Number of CD4 SP TCRb+ thymocytes in 1- to 2-month-old mice (n = 13). ***p < 0.001.
Graphed results are means with error bars representing SD. See also Figure S4.
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normal SP thymocytes but do demonstrate some defects.
CCR7 and IL-7Ra upregulation upon positive selection are
shown here to be Id-dependent events and probably require
Id-mediated E protein downregulation.
The Id2f/fId3f/fCd4cre+ CD4 SP population was next analyzed
for expression of HSA and TCR usage. HSA expression was
downregulated in this compartment, consistent with an SP-like
phenotype (Figure 5D). However, there was an increase in the
percentage of HSAlo cells within the Id2f/fId3f/fCd4cre+ CD4 SP
population. This could be due to a delay in exiting the thymus
and/or expansion of this population. Although the CD4 SP pop-
ulation in these animals did not appear to result simply from
clonal expansion of a few cells proceeding to the CD4 SP stageprior to complete deletion, the Id2f/fId3f/fCd4cre+ CD4 SP cells
did display more variation in usage of TCRb and TCRa chains
from animal to animal when compared to cre controls (Fig-
ure S5A). This result may reflect expansion within a fraction of
the CD4 SP thymocytes or could be due to alterations in TCR
selection. Nonetheless, only one out of the four mice analyzed
demonstrated a dominant Vb and Va TCR usage among the
specific chains examined, suggesting that although expansion
may be occurring in a fraction of CD4 SP thymocytes, a relatively
diverse population of CD4 SP thymocytes is being generated in
the absence of Id2 and Id3.
We further investigated the MHC restriction of these Id-defi-
cient CD4 SP thymocytes. First, mouse CD1d tetramer staining
demonstrated that the majority of TCRb+ CD4 SP thymocytesImmunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc. 353
Figure 5. CCR7 and IL-7Ra Fail to Be Efficiently Upregulated in Id2f/fId3f/fCd4cre+ CD4 SP Thymocytes
(A) Representative staining of thymus from indicated genotypes. Plots are pregated on DP (CD4+CD8+) or CD4 SP (CD4+CD8TCRb+) thymocytes and
percentages in each quadrant are displayed. Percent means ± SD for total CCR7+ thymocytes within the CD4 SP compartment were 78 ± 8.0 for cre (n = 6) and
25 ± 12 for cre+ (n = 6), with a significant difference (p < 0.001). Percent means ± SD for total CXCR4 thymocytes within the CD4 SP compartment were 86 ±
4.6 for cre (n = 4) and 80 ± 12 for cre+ (n = 4).
(B) Representative staining of thymus with histograms pregated on DP and CD4 SP thymocytes as described in (A). Percentages within the IL-7Ra+ gate are
displayed. Percent means ± SD for IL-7Ra+ thymocytes within the CD4 SP compartment were 55 ± 4.1 for cre (n = 3) and 3.7 ± 1.6 for cre+ (n = 3), with
a significant difference (p < 0.001).
(C) Quantitative RT-PCR analysis of KLF2 and Tox expression in sorted DP (CD4+CD8+) and CD4 SP (CD4+CD8TCRb+) thymocytes. Duplicate runs from
a sample sorted from an individual animal (n = 3 for cre DP, cre+ DP, cre CD4 SP; n = 4 for cre+ CD4 SP) were averaged and normalized to the expression of
Gapdh. Graphed results are means with error bars representing SEM.
(D) Representative staining of thymus with histograms pregated on DP and CD4 SP thymocytes as described in (A). Percentages within the HSAlo gate are
displayed (HSA clone M1/69 was used). Percent means ± SD for HSAlo thymocytes within the CD4 SP compartment were 53 ± 6.0 for cre (n = 4) and 86 ± 8.4
for cre+ (n = 4), with a significant difference (p < 0.001).
Plots in (A), (B), and (D) are from analysis of the same individuals. See also Figure S5.
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E Proteins Allow for CD4+ Lineage Choicein Id2f/fId3f/fCd4cre+ animals are not invariant NK T cells (Fig-
ure S5B). Second, upon Id2f/fId3f/fCd4cre+ bone marrow trans-
fer to congenic MHC II-deficient recipients, donor cells are354 Immunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc.capable of efficiently reconstituting the DP but neither the
CD8 SP nor CD4 SP compartment (Figure S5C). A small
amount of donor-derived TCRb+ CD4 SP thymocytes were
Immunity
E Proteins Allow for CD4+ Lineage Choiceobserved in the MHC II-deficient recipients, but the percentage
was greatly diminished when compared to the TCRb+ CD4
SP population generated from the same donor cells when
transferred to control wild-type or Rag2-deficient recipients.
Together, these data imply that the majority of TCRb+ CD4
SP thymocytes developing in the Id2f/fId3f/fCd4cre+ mice are
MHC II restricted.
The block in CD8 SP production and permission of CD4 SP
development upon removal of Id2 and Id3 further support a differ-
ential role for E proteins in regulating CD4+ versus CD8+ lineage
development. The Id2f/fId3f/fCd4cre model suggests that in
addition to E proteins being required for CD4+ lineage choice,
disruption of the amount and/or timing of E protein downregula-
tion may be sufficient to drive CD4+ lineage production over
CD8+ development.
E Proteins Are Required prior to CD4+ Lineage
Specification
Thephenotypes of the Eprotein-deficient and Id-deficientmouse
models both support a role for E proteins positively regulating
the generation of CD4+ T cells. We next sought to determine at
which point E proteins are required during the CD4+ lineage
developmental program. For this purpose, we first analyzed
expression of the CD4-specific transcriptional regulator ThPOK.
ThPOK expression is initiated and maintained after TCR-medi-
ated positive selection for the commitment of MHC II-restricted
thymocytes to the CD4+ lineage (He et al., 2005, 2008; Sun
et al., 2005). Therefore, ThPOK expression can be used as
a marker of CD4+ lineage identity. We crossed Tcf12f/fTcfe2af/f
Cd4cre+ mice with a ThPOK reporter strain (denoted here as
TR) that expresses GFP under the control of Thpok regulatory
elements (He et al., 2008). Analysis of Tcf12f/fTcfe2af/fCd4cre+
TR+ mice demonstrated no significant GFP+ population within
the CD8 SP TCRb+ or CD8 SP TCRb gates above the back-
ground observed in creTR+ CD8 SP TCRb+ controls (Figure 6A).
This result suggested that therewere nocells initially adopting the
CD4+ lineage fate within the CD8 SP compartment. Similar to the
Tcf12f/fTcfe2af/fCd4creTR+ control mice, GFP expression in
Tcf12f/fTcfe2af/fCd4cre+TR+ mice was primarily restricted to the
CD4+CD8lo and CD4 SP compartments. Although there are
very few cells within the CD4+CD8lo and CD4 SP compartments
in E protein-deficient mice, we did detect ThPOK expression
among these cells, consistent with a previous finding that E
proteinswere not required formaintenance of ThPOKexpression
in mature T cells (data not shown). However, the vast majority of
cells, which lost E protein activity and by-passed the requirement
for positive selection, were unable to activate ThPOK expression
and were unable to undergo CD4+ lineage development.
Analysis of Id2f/fId3f/fCd4cre+ mice demonstrated that pheno-
typically, the development of CD4 SP TCRb+ thymocytes was
intact (Figure 4). However, to ensure that these cells were tran-
scriptionally initiating the CD4+ lineage fate, expression of
ThPOK within Id2f/fId3f/fCd4cre+ CD4 SP cells was examined
as well. As expected, ThPOK expression was detected in CD4
SP thymocytes from Id2f/fId3f/fCd4cre+ mice and was within
the range of ThPOK expression from Id2f/fId3f/fCd4cre controls
for four of the five animals examined (Figures 6B and S6A). These
data suggest that activation of ThPOK expression can occur
independently of TCR-mediated Id upregulation.The transcription factor Gata3 has been shown to regulate
CD4+ lineage specification and does so in part by allowing acti-
vation of ThPOK expression (Wang et al., 2008). In addition,
Gata3 expression is upregulated during the DP to SP transition
primarily in MHC II-restricted cells entering the CD4+ lineage
(Hendriks et al., 1999; Herna´ndez-Hoyos et al., 2003). Therefore,
we next investigated whether E proteins are required upstream
or downstream of Gata3 upregulation by analyzing Gata3
expression in our E protein-deficient and Id-deficient mouse
models. Intracellular staining of Gata3 in Tcf12f/fTcfe2af/f
Cd4cre+ mice displayed a decrease in the percentage of posi-
tively selected thymocytes expressing higher amounts of
Gata3, indicating a defect in specification of CD4+ lineage
thymocytes (Figures 6C, S6B, and S6C). In addition, cells ex-
pressing high amounts of Gata3 were not detected in the CD8
SP compartment. These results indicate that Gata3 upregulation
fails to be induced in the absence of HEB and E2A.
Complimentary to the E protein-deficient analysis, Gata3 up-
regulation was efficiently induced in Id2f/fId3f/fCd4cre+ mice for
the development of CD4 SP thymocytes. After initiation, more
cells expressed higher amounts of Gata3 (Figure 6C). Overlay
of the recently selected populations suggested that the amount
of Gata3 in Id2f/fId3f/fCd4cre+ CD4+CD8lo cells had already
started to resolve, as it did in the CD4 SP stage in the control
cells (Figure S6C). However, this intermediate amount of expres-
sion persisted through the CD4 SP stage in the Id-deficient
animals. Together, these results further support that E proteins
play a positive role in regulating Gata3 expression. Cells
receiving a TCR-mediated positive selection signal in the
absence of Id2 and Id3 can initiate Gata3 upregulation, consis-
tent with a role for HEB and E2A upstream of initiation of CD4+
lineage specification.
The absence of ThPOK and Gata3 expression in the CD8+
T cell compartment of E protein-deficient mice suggests that
CD4+ lineage development was blocked prior to induction of
these factors and demonstrates that the phenotypic CD8+
compartment did not contain any transcriptionally defined
CD4+ lineage cells. To further analyze the transcriptional profile
of these cells, we examined expression of the CD8+ lineage tran-
scriptional regulator Runx3 (Collins et al., 2009). Runx3 expres-
sion was assessed by amplifying transcripts from the distal
Runx3 promoter, specific to the CD8+ lineage (Egawa et al.,
2007). CD8 SP thymocytes from Tcf12f/fTcfe2af/fCd4cre+ mice
did express Runx3, and amounts were comparable to that of
cre control CD8 SP cells (Figure S6D). In addition, a faint
Runx3 product was detected in the DP compartment in one of
the two Tcf12f/fTcfe2af/fCd4cre+ animals analyzed, above that
of the cre and B6 controls. This finding is consistent with the
premature CD8 SP-like development occurring in Tcf12f/f
Tcfe2af/fCd4cre+ DP thymocytes (Jones and Zhuang, 2007).
E Proteins Promote CD4+ Lineage Development beyond
Regulation of CD4 Expression
E proteins have previously been shown to regulate expression of
the TCR coreceptor CD4 (Sawada and Littman, 1993), andmain-
tenance of CD4 expression is important for signaling CD4+
lineage differentiation (Sarafova et al., 2005). Therefore, we
investigated whether a defect in CD4 expression upon removal
of HEB and E2A was responsible for the block in CD4+ T cellImmunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc. 355
Figure 6. E Proteins Function Upstream of ThPOK and Gata3 Induction
(A) Tcf12f/fTcfe2af/fCd4cre+ mice were crossed onto a ThPOK reporter (TR) background. Staining of indicated genotypes for reporter induced GFP expression.
Controls (shaded) are fromwild-type (B6) mice. Histograms are pregated on specified thymic populations, and the percent GFP+ is indicated and was determined
with the gate shown. Percent means ± SD for the GFP+ compartment were 0.86 ± 0.53 for creTR+ CD8 SP TCRb+ (n = 3), 0.19 ± 0.072 for cre+TR+ CD8 SP TCRb+
(n = 4), and 0.027 ± 0.021 for cre+TR+ CD8 SP TCRb (n = 4). CD8 SP TCRb+ wild-type cells were used for the background control staining shown in both the CD8
SP TCRb+ and CD8 SP TCRb plots. Total thymocyte cell number means ± SD (3108) for 1- to 2-month-old mice were 1.4 ± 0.67 for creTR+ (n = 3) and 0.88 ±
0.42 for cre+TR+ (n = 3).
(B) Quantitative RT-PCR analysis of ThPOK expression in sorted CD4 SP TCRb+ thymocytes from Id2f/fId3f/fCd4cre and Id2f/fId3f/fCd4cre+ mice (gating strategy
shown in Figure S6A). Samples were normalized to the expression of Gapdh. Each dot represents the average of triplicate runs for a sample sorted from an
individual animal, with n = 3 for cre and n = 5 for cre+. The line displays the mean value for each genotype. Serving as a negative control, ThPOK product was
undetectable in cre and cre+ DP samples (n = 3) by this method.
(C) Intracellular staining for Gata3 expression in Tcf12f/fTcfe2af/fCd4cre+, Id2f/fId3f/fCd4cre+, and Id2f/fId3f/fCd4cre control mice. Plots are pregated on specified
thymic populations and display isotype control staining (shaded) and anti-Gata3 staining (line). Id2f/fId3f/fCd4cre isotype controls were used for all subsets
shown except for the CD8 SP TCRb plot, which displays the Tcf12f/fTcfe2af/fCd4cre+ isotype control. Histograms are subdivided into three increasing amounts
of Gata3 expression. Percentages for anti-Gata3 staining in each of these gates are displayed.
Data are representative of three independent experiments. See also Figure S6.
Immunity
E Proteins Allow for CD4+ Lineage Choice
356 Immunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc.
Figure 7. Addition of a Cd4 Transgene Fails to Rescue the CD4+ T Cell Defect in E-Protein-Deficient Mice
Tcf12f/fTcfe2af/fCd4cre+ mice were crossed onto a Cd4 transgenic background.
(A) Representative staining of thymus from indicated genotypes. Histograms are pregated on the CD4 SP gate, as shown. Percentages in each gated population
are displayed.
(B) Cell number in the thymus of 1- to 2-month-old mice.
(C) Number of CD4 SP TCRb+ thymocytes in 1- to 2-month-old mice.
(B and C) Control n = 9, cd4Tg n = 8,Cd4cre n = 6,Cd4creCd4Tg n = 10. For cell counts, control and Cd4cre animals were either +/+ or +/ for endogenous Cd4,
and Cd4Tg and Cd4creCd4Tg animals were +/+, +/, or / for endogenous Cd4. We detected no effect on cell numbers with these variations in the
endogenous Cd4 background. ***p < 0.001, **p = 0.0018, and *p = 0.0091. Graphed results are means with error bars representing SD.
See also Figure S7.
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of a Cd4 transgene (Van Laethem et al., 2007) could rescue
CD4 development in the Tcf12f/fTcfe2af/fCd4cre+ mice.
If a Cd4 transgene were able to rescue CD4+ lineage devel-
opment in the absence of HEB and E2A, we would expect
to see an increase in the CD4 SP population, potentially
at the expense of CD8+ lineage development. Even though
Tcf12f/fTcfe2af/fCd4cre+Cd4Tg+ mice did show a slight in-
crease in the percentage of CD4+CD8 thymocytes compared
to Tcf12f/fTcfe2af/fCd4cre+ mice, CD4 SP TCRb+ cells made uponly a fraction of the cells in that gate (Figure 7A). In mice that
carry the Cd4 transgene, which is expressed throughout T cell
development, the CD4 SP gate also contained double-negative
thymocytes, and the DP gate also contained CD8 SP cells.
Whereas the total number of thymocytes was slightly reduced
in Tcf12f/fTcfe2af/fCd4cre+Cd4Tg+ mice compared to controls,
the number of CD4 SP TCRb+ cells in these animals was signif-
icantly reduced from that of Tcf12f/fTcfe2af/fCd4creCd4Tg
and Tcf12f/fTcfe2af/fCd4creCd4Tg+ mice (Figures 7B and
7C). Additionally, there was no increase in the CD4 SP TCRb+Immunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc. 357
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indicating that the Cd4 transgene could not rescue CD4+
lineage development.
Analysis of peripheral T cell populations also demonstrated
this failure of the Cd4 transgene to rescue CD4+ T cells in the
absence of HEB and E2A (Figure S7). In addition, the large pop-
ulations of CD8 TCRb+ and TCRb cells detected in Tcf12f/f
Tcfe2af/fCd4cre+ mice continued to be produced in Tcf12f/f
Tcfe2af/fCd4cre+Cd4Tg+ mice. Therefore, the requirement for E
proteins that allows for CD4+ lineage differentiation is distinct
from E proteins’ role in regulating CD4 expression.
DISCUSSION
Here, we have demonstrated a specific requirement for
E proteins in the generation of CD4+ lineage T cells. Previous
analysis had shown that E proteins play a pivotal role in regulating
DP survival and positive selection, but it is clear from the present
study that E protein function extends to the regulation of CD4+
versus CD8+ lineage choice as well. Not only are E proteins
required for the initiation of CD4+ lineage development, but
they are also required to prevent entry of MHC II-restricted
thymocytes into the CD8+ lineage. Therefore, in addition to
enforcing the requirement for a TCR at the positive selection
step, HEB and E2A also enforce matching of the TCR with the
appropriate coreceptor.
The conditional removal of both Id2 and Id3 at the DP stage
revealed a phenotype supporting these findings, which had not
previously been seen with either Id2 or Id3 deficiency alone
(Guo et al., 2011; Pan et al., 1999; Rivera et al., 2000; Yokota
et al., 1999). Removal of Id proteins is anticipated to disrupt
the downregulation of E proteins in response to a TCR-mediated
positive selection event. The finding that CD4+ development
although limited can proceed, whereas CD8 development is
blocked, suggests that persistent E protein activity during posi-
tive selection permits CD4+ lineage development while prevent-
ing CD8+ lineage development.
The identification of a phenotype dependent on the deletion of
both Id2 and Id3 is reminiscent of that seen with the analysis of
the Tcf12 and Tcfe2a double conditional model (Jones and
Zhuang, 2007; Wojciechowski et al., 2007). In both cases,
functions are revealed that were previously masked by redun-
dant factors. Just as HEB and E2A serve redundant function to
regulate the DP to SP transition, Id2 and Id3 probably serve
redundant function, at least in part, to regulate E protein down-
regulation during this developmental window. Even though the
kinetics of Id2 upregulation are probably slower (Schmitz et al.,
2003) and Id2 expression was not altered during ab T cell devel-
opment in the absence of Id3 (data not shown), Id2 is sufficient in
the absence of Id3 to allow for CD8+ lineage development. The
fact that CD4+ T cells continue to develop in the absence of
both Id2 and Id3, but CD8+ T cells do not, suggests that CD4+
lineage differentiation and CD8+ lineage differentiation may
have differential requirements for the complete downregulation
of E proteins. Although this is a topic of interest that we are
continuing to pursue, the findings here from the Id2f/fId3f/f
Cd4cre+ model strongly correlate with a role for E proteins in
driving CD4+ development and blocking CD8+ development.
We anticipate that the overall dosage of E proteins and Id358 Immunity 36, 348–361, March 23, 2012 ª2012 Elsevier Inc.proteins is critical to properly regulate development of the
CD4+ and CD8+ lineages.
The Id2f/fId3f/fCd4cre model also provides a means to inves-
tigate which events during the DP to SP transition are Id depen-
dent versus Id independent. In addition, comparison of the
results from this work with the previous data from the Tcf12f/f
Tcfe2af/fCd4cre model (Jones and Zhuang, 2007) allows us
to begin identifying which targets are E protein dependent.
For example, the upregulation of both CCR7 and IL-7Ra as
cells enter the SP stage were shown here to be Id-dependent
events. Because the upregulation in expression of these
receptors was blocked in the absence of Id proteins and
induced upon removal of E proteins, CCR7 and IL-7Ra are
probably repressed by E protein activity and dependent on
E protein downregulation for their induction. We anticipate
that this combinatorial approach of using both Id-deficient
and E-protein-deficient mouse models will help to identify
which E protein targets may be involved in coordinating lineage
determination.
When considering the possible mechanisms by which E
proteins regulate lineage choice in positively selected cells,
one hypothesis could be that the extent of E protein downregu-
lation functions as a sensor for TCR signal strength. Current
models suggest that stronger or prolonged TCR signals are
important for driving CD4+ lineage development (He et al.,
2010). It has been proposed that signal strength positively corre-
lates with Id3 activation, and Id3-deficient animals have been
shown to have a more severe positive selection defect in mice
expressing a MHC II-restricted TCR transgene over mice
expressing a MHC I-restricted transgene (Alonzo et al., 2010;
Bain et al., 2001; Rivera et al., 2000). However, this model cannot
explain the results from our Id2 and Id3 double conditional
deletion system. We have shown that the removal of Id2 and
Id3 resulted in opposite outcomes: CD8 SP development was
blocked and CD4 SP development persisted. These results
suggest that in addition to sensing TCR signals, E proteins also
serve additional functions to regulate lineage choice during the
DP to SP developmental window. Therefore, we propose that
the timing and degree of E protein downregulation during the
DP to SP transition is critical for the proper regulation of CD4+
versus CD8+ lineage development. Complete removal of HEB
and E2A at the DP stage in our Tcf12 and Tcfe2a double condi-
tional deletion system prevented E proteins from carrying out
these lineage defining functions.
The requirement for E proteins in the development of CD4+
lineage T cells could be direct or indirect. Prior to this study,
one could have speculated that the reduction in CD4+ T cells in
the absence of E proteins was due to a loss of CD4 expression.
However, we have shown here that providing a Cd4 transgene is
not sufficient to rescue CD4+ lineage development in the
absence of HEB and E2A. Still, E proteins may be directly
involved in driving expression of other critical CD4+ lineage
factors. For example, E proteins may be directly required to
induce Gata3 expression; previous studies have already sug-
gested E protein regulation of Gata3 (Gre´goire and Rome´o,
1999; Schwartz et al., 2006). Even though these studies have
primarily described E proteins as repressors of Gata3 expres-
sion, the outcome of E-protein-mediated regulation of target
genes can be cell context specific. Although it is possible that
Immunity
E Proteins Allow for CD4+ Lineage ChoiceE proteins may also directly activate ThPOK, there would prob-
ably be an additional requirement for activation of Gata3 or
another unknown upstream regulator because rescuing ThPOK
expression in the absence of Gata3 is not sufficient to restore
CD4+ lineage development (Wang et al., 2008).
Alternatively, E proteins may promote CD4+ lineage develop-
ment by repressing CD8+ lineage factors. For example, if E
proteins were responsible for repression of Runx3, activation
of Runx3 by removal of HEB and E2A could contribute to inhibi-
tion of CD4+ lineage development, but would probably be only
one of several events mediating the E-protein-deficient pheno-
type (Grueter et al., 2005; Kohu et al., 2005). In addition to regu-
lating transcription factors, E proteins may be regulating other
factors that, for example, influence interpretation of extracellular
signals or thymocyte migration. Cytokine signaling has been
suggested to play an important role in CD8+ lineage develop-
ment (Park et al., 2010), and E proteins could function to repress
CD8+ lineage development by regulating the receipt of cytokine
signals or the migration of cells to cytokine-expressing environ-
ments. This is of particular interest given the defects in IL-7Ra
and CCR7 expression in the Id2f/fId3f/fCd4cre+ model.
E proteins probably function to regulate CD4+ and CD8+
lineage development through activation and/or repression of
multiple targets. Here, our data place E proteins upstream of
Gata3 upregulation, which is one of the earliest known CD4+
lineage specification events. In addition, the data show that the
requirement for E proteins to initiate CD4+ lineage development
extends beyond regulation of the E protein target CD4. Future
investigation of the potential targets described above, and
others, will not only further define the role of E proteins but will
also serve to provide mechanistic insight for how a developing
thymocyte chooses CD4+ versus CD8+ lineage fate.
EXPERIMENTAL PROCEDURES
Mice
Bim-deficient, OT-II transgenic, and Id3RFP reporter mice are from The Jack-
son Laboratory. MHC I- and II-deficient mice are from Taconic. Tcf12 condi-
tional, Tcfe2a conditional, Cd4cre transgenic, Id3 conditional, Cd4 transgenic,
and ThPOK reporter (F2F3 line) mice have been described previously (Guo
et al., 2011; He et al., 2008; Pan et al., 2002; Van Laethem et al., 2007; Wojcie-
chowski et al., 2007; Wolfer et al., 2001). Generation of the Id2 reporter
line Id2hCD5 is described below. Id2 conditional mice were generated in the
laboratory of A.I. and A.L. and will be further described in another publication.
All research with mice was performed in accordance with relevant guidelines,
and protocols were approved by the Duke University Animal Care and Use
Committee.
Generation of the Id2hCD5 Allele
The Id2hCD5 allele was generated by creating a targeting construct that
inserted an IRES hCD5 cassette into the 30 UTR of Id2’s exon 3. The targeting
construct also contained a floxed, positive selection marker, PGKNeo
cassette, and a negative selection marker, PGKDT cassette. Mouse ES cells
were derived from a 129/sv strain obtained from P. Soriano’s lab in 1995
and then maintained in our own lab. Id2hCD5 mice were maintained on a
C57BL/6 and 129/sv mixed background. The floxed PGKNeo cassette was
deleted by crossing the Id2hCD5 mice with Prm-cre transgenic mice (Jackson
Laboratory). All analysis here was donewithmice obtained after PGKNeo dele-
tion. Genotyping details can be found in the Supplemental Information.
Cell Staining and Flow Cytometry
Staining for hCD5 was done with anti-human CD5 biotin (UCHT2, BD
PharMingen, BD Biosciences), followed by SA-PECy7 staining. For intracel-lular staining, the Foxp3 Staining Buffer Set (eBioscience) was used for fixation
and permeabilization. The following antibodies were used for analysis of
intracellular Gata3 expression: mouse anti-Gata3 (L50-823, BD PharMingen,
BD Biosciences) and mouse IgG1 k isotype control (MOPC-21, BD Phosflow,
BDBiosciences). Themouse CD1d PBS57-loaded and unloaded control tetra-
mers were from the NIH tetramer facility. Flow cytometry analysis was done
with a FACSCalibur (BD Biosciences) or FACSCanto II (BD Biosciences) and
FlowJo software (Tree Star). Flow cytometry plots were pregated on 7-amino-
actinomycin D (7AAD, Molecular Probes) negative (live) lymphocytes, and
doubletswere eliminatedwhen possible by using a forward scatter area versus
forward scatter height gate. FACSVantage SE with DiVa option (BD Biosci-
ences) was used for cell sorting. All flow cytometry plots displayed together
were analyzed simultaneously unless noted otherwise.
Reverse Transcriptase-Polymerase Chain Reaction
RNA extraction, DNase I treatment, and reverse transcription have been
described previously (Lazorchak et al., 2006). Quantitative real-time PCR
analysis for KLF2, Tox, and ThPOK expression was performed with a Roche
LightCycler and the Fast-Start DNA master SYBR green kit I (Roche) or
QuantiFast SYBR Green PCR Kit (QIAGEN). The following primers were
used: ThPOK primers for (50-GTTCACAGATGCCCCAAGAG-30) and rev1 (50-G
AAGGCCTTGTGGCACAGGTG-3), KLF2 primers (Jones and Zhuang, 2007),
Tox primers (Wilkinson et al., 2002), and GAPDH primers (Lazorchak et al.,
2006). Molecular weight markers used were 1 kb and 1 kb Plus (Invitrogen).
Statistical Analysis
Statistical analysis was performed with GraphPad Prism software and statis-
tical significance was assessed by the two-tailed Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and can be found with this
article online at doi:10.1016/j.immuni.2012.02.010.
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